Application of the Filariasis CELISA Antifilarial IgG_𝟒 Antibody Assay in Surveillance in Lymphatic Filariasis Elimination Programmes in the South Pacific

Figure 1

Prevalence rates of the diagnostic parameters: Mf, CFA, and antibody in children. There was a significantly lower antibody (Ab) prevalence in children in Vanuatu and Tonga and a significantly higher antibody prevalence in children in Samoa (𝜒²=549.3; 𝑑𝑓=3; 𝑃<0.001). There were no Mf or CFA positive children detected in either Vanuatu or Tonga.